A Pilot Study to Evaluate the PK Profile of PrimeC-ER Tablets in Healthy Adult Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 8, 2022

Primary Completion Date

April 21, 2022

Study Completion Date

August 30, 2022

Conditions

Pharmacokinetics

Interventions

DRUG

PrimeC-ER 748 mg

PrimeC-ER is an extended release formulation of a fixed dose combination of ciprofloxacin and celecoxib

DRUG

Ciprofloxacin 750 MG

Ciprofloxacin

DRUG

Celecoxib 200mg

Celecoxib

Trial Locations (1)

Novum, Fargo